We are live on ! Find out more
TPA

Trivium Point Advisory Portfolio holdings

AUM $553M
1-Year Est. Return 26.47%
This Fund
S&P 500
This Quarter Est. Return
+11.69%
1 Year Est. Return
+26.47%
3 Year Est. Return
+86.73%
5 Year Est. Return
+93.38%
10 Year Est. Return
AUM
$465M
AUM Growth
+$52.3M
Cap. Flow
+$15.3M
Cap. Flow %
3.3%
Top 10 Hldgs %
28.14%
Holding
234
New
33
Increased
95
Reduced
71
Closed
15

Top Sells

Rank Stock Value
1
EQIX icon
Equinix
EQIX
+$3.09M
2
GILD icon
Gilead Sciences
GILD
+$2.01M
3
ACN icon
Accenture
ACN
+$1.55M
4
ARCC icon
Ares Capital
ARCC
+$1.2M
5
EMR icon
Emerson Electric
EMR
+$1.14M

Sector Composition

Rank Sector Weight
1 Technology 18.51%
2 Financials 12.05%
3 Communication Services 11.18%
4 Consumer Discretionary 8.69%
5 Healthcare 7.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WHR icon
176
Whirlpool
WHR
$2.49B
$391K 0.08%
3,265
-565
-15% -$63K
VEEV icon
177
Veeva Systems
VEEV
$33.8B
$378K 0.08%
1,631
+28
+2% +$6.04K
WEN icon
178
Wendy's
WEN
$1.46B
$378K 0.08%
20,050
-4,305
-18% -$80.9K
VTI icon
179
Vanguard Total Stock Market ETF
VTI
$646B
$376K 0.08%
1,448
+160
+12% +$39.6K
COR icon
180
Cencora
COR
$62B
$375K 0.08%
1,543
URA icon
181
Global X Uranium ETF
URA
$5.21B
$375K 0.08%
+13,003
New +$376K
INDA icon
182
iShares MSCI India ETF
INDA
$6.81B
$348K 0.07%
+6,741
New +$340K
TGT icon
183
Target
TGT
$66.3B
$341K 0.07%
1,922
-3
-0.2% -$456
BX icon
184
Blackstone
BX
$104B
$336K 0.07%
2,560
-257
-9% -$32.1K
BMY icon
185
Bristol-Myers Squibb
BMY
$129B
$333K 0.07%
6,149
+1,493
+32% +$76.1K
META icon
186
Meta Platforms (Facebook)
META
$1.49T
$333K 0.07%
686
-165
-19% -$73.6K
ORCL icon
187
Oracle
ORCL
$339B
$304K 0.07%
2,417
-11
-0.5% -$1.26K
ACWI icon
188
iShares MSCI ACWI ETF
ACWI
$32B
$298K 0.06%
+2,703
New +$284K
CYBR
189
DELISTED
CyberArk
CYBR
$288K 0.06%
+1,083
New +$268K
SNOW icon
190
Snowflake
SNOW
$98.1B
$285K 0.06%
+1,761
New +$341K
AMD icon
191
Advanced Micro Devices
AMD
$700B
$277K 0.06%
+1,533
New +$268K
MRSH
192
Marsh
MRSH
$94.3B
$269K 0.06%
+1,308
New +$261K
CCI icon
193
Crown Castle
CCI
$34.6B
$268K 0.06%
2,532
-40
-2% -$4.35K
SPYM
194
State Street SPDR Portfolio S&P 500 ETF
SPYM
$157B
$260K 0.06%
4,232
-265
-6% -$15.5K
FXY icon
195
Invesco CurrencyShares Japanese Yen Trust
FXY
$427M
$259K 0.06%
+4,227
New +$264K
IGIB icon
196
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.5B
$250K 0.05%
4,853
DKNG icon
197
DraftKings
DKNG
$12.2B
$246K 0.05%
+5,417
New +$220K
EW icon
198
Edwards Lifesciences
EW
$49.4B
$239K 0.05%
2,505
-803
-24% -$67.5K
MU icon
199
Micron Technology
MU
$835B
$236K 0.05%
+2,000
New +$181K
TYL icon
200
Tyler Technologies
TYL
$13.7B
$234K 0.05%
550

Similar funds

Trivium Point Advisory's Q1 2024 Portfolio in Review

As of Q1 2024, Trivium Point Advisory held 234 positions worth $465M, up 13% from $412M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Trivium Point Advisory deployed $15.3M of net new capital in Q1 2024, opening 33 new positions and adding to 95 existing holdings. Its largest new stake was Novo Nordisk: 15,573 shares worth $2M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was Accenture, an estimated $1.55M trimmed.

  • Trivium Point Advisory's largest Q1 2024 buy was Novo Nordisk: 15,573 shares worth $2M.
  • Trivium Point Advisory added most to Walt Disney in Q1 2024, an estimated $1.17M increase.
  • Trivium Point Advisory's biggest Q1 2024 reduction was Accenture, cutting an estimated $1.55M.
  • Trivium Point Advisory fully exited Equinix in Q1 2024, selling an estimated $3.09M.
  • Trivium Point Advisory's ten largest holdings make up 28% of its $465M portfolio in Q1 2024.
  • Trivium Point Advisory opened 33 new positions and closed 15 in Q1 2024.
  • Trivium Point Advisory's portfolio value rose 13% quarter-over-quarter to $465M.

Based on Trivium Point Advisory's 13F filing for Q1 2024, filed 15 May 2024.